Cyclotron vs generator-produced 68Ga PSMA: a single-institution, prospective clinical trial

The clinical utility of gallium 68 ((68)Ga)-PSMA PET for the diagnosis and management of prostate cancer is driven in part by radioisotope availability and production costs. This study evaluates the equivalence between the two manufacturing processes for (68)Ga-PSMA: (68)Ga-PSMA-cyclotron (from a so...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez, Juana, Subramanian, Kritika, Castellanos, Sandra Huicochea, Thomas, Charlene, Choudhury, Arindam Roy, Muench, Brett, Tagawa, Scott T., Pillarsetty, Naga Vara Kishore, Osborne, Joseph R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803810/
https://www.ncbi.nlm.nih.gov/pubmed/36571987
http://dx.doi.org/10.1016/j.tranon.2022.101593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803810/
https://www.ncbi.nlm.nih.gov/pubmed/36571987
http://dx.doi.org/10.1016/j.tranon.2022.101593

Ejemplares similares